Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Background: Network science provides powerful access to essential organizational principles of the brain. The aim of this study was to investigate longitudinal evolution of gray matter networks in early relapsing–remitting MS (RRMS) compared with healthy controls (HCs) and contrast network dynamics...

Full description

Bibliographic Details
Main Authors:	Vinzenz Fleischer, Nabin Koirala, Amgad Droby, René-Maxime Gracien, Ralf Deichmann, Ulf Ziemann, Sven G. Meuth, Muthuraman Muthuraman, Frauke Zipp, Sergiu Groppa
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-04-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/1756286419838673

Similar Items

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
by: Timo Uphaus, et al.
Published: (2021-10-01)

Structural brain network characteristics can differentiate CIS from early RRMS
by: Muthuraman eMuthuraman, et al.
Published: (2016-02-01)

Network alterations underlying anxiety symptoms in early multiple sclerosis
by: Erik Ellwardt, et al.
Published: (2022-05-01)

Choroid plexus imaging to track neuroinflammation – a translational model for mouse and human studies
by: Muthuraman Muthuraman, et al.
Published: (2023-01-01)

Brain Networks Reorganization During Maturation and Healthy Aging-Emphases for Resilience
by: Gabriel Gonzalez-Escamilla, et al.
Published: (2018-11-01)

Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis
by: Dumitru Ciolac, et al.
Published: (2019-07-01)

EEG-Based Mapping of Resting-State Functional Brain Networks in Patients with Parkinson’s Disease
by: Sarah Leviashvili, et al.
Published: (2022-12-01)

Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease
by: Muthuraman Muthuraman, et al.
Published: (2018-08-01)

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
by: René-Maxime Gracien, et al.
Published: (2016-01-01)

Toward future adaptive deep brain stimulation for Parkinson’s disease: the novel biomarker — narrowband gamma oscillation
by: Hao Ding, et al.
Published: (2022-01-01)

Comparative effectiveness of natalizumab ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
by: Katrin Pape, et al.
Published: (2022-12-01)

Linking Microstructural Integrity and Motor Cortex Excitability in Multiple Sclerosis
by: Angela Radetz, et al.
Published: (2021-10-01)

Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
by: Alexandru Hanganu, et al.
Published: (2017-01-01)

Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
by: Hanganu Alexandru, et al.
Published: (2016-01-01)

Myelination- and immune-mediated MR-based brain network correlates
by: Manuela Cerina, et al.
Published: (2020-06-01)

Reduced Cross-Frequency Coupling and Daytime Sleepiness in Obstructive Sleep Apnea Patients
by: Haralampos Gouveris, et al.
Published: (2022-05-01)

Structural brain network fingerprints of focal dystonia
by: Venkata C. Chirumamilla, et al.
Published: (2019-11-01)

Structural brain network characteristics in patients with episodic and chronic migraine
by: Lars Michels, et al.
Published: (2021-03-01)

Treadmill training in Parkinson’s disease is underpinned by the interregional connectivity in cortical-subcortical network
by: Hao Ding, et al.
Published: (2022-11-01)

Machine learning aided classification of tremor in multiple sclerosis
by: Abdulnasir Hossen, et al.
Published: (2022-08-01)

Alterations in White Matter Network and Microstructural Integrity Differentiate Parkinson’s Disease Patients and Healthy Subjects
by: Nabin Koirala, et al.
Published: (2019-07-01)

EEG and MEG primers for tracking DBS network effects
by: Vladimir Litvak, et al.
Published: (2021-01-01)

Sensorimotor Cortical Activity during Respiratory Arousals in Obstructive Sleep Apnea
by: Katharina Bahr-Hamm, et al.
Published: (2022-12-01)

Differential contributions of the two human cerebral hemispheres to action timing
by: Anja Pflug, et al.
Published: (2019-11-01)

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
by: Friedemann Paul, et al.
Published: (2008-04-01)

The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients
by: Amgad Droby, et al.
Published: (2015-01-01)

Intensity of Respiratory Cortical Arousals Is a Distinct Pathophysiologic Feature and Is Associated with Disease Severity in Obstructive Sleep Apnea Patients
by: Katharina Bahr, et al.
Published: (2021-02-01)

Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management
by: Stefan Bittner, et al.
Published: (2017-01-01)

Treadmill training in Parkinson’s disease: possible role of prefrontal modifications in the improved cortical-subcortical network function
by: Hao Ding, et al.
Published: (2024-01-01)

The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis
by: Lars Masanneck, et al.
Published: (2020-12-01)

Cortical Excitability and Interhemispheric Connectivity in Early Relapsing–Remitting Multiple Sclerosis Studied With TMS-EEG
by: Carl M. Zipser, et al.
Published: (2018-06-01)

Longitudinal cortex reorganization and white matter tracts structural changes analysis in relapsing-remitting multiple sclerosis patients with hand palsy
by: S. N. Kulikova, et al.
Published: (2017-02-01)

Dynamic flexibility and controllability of network communities in juvenile myoclonic epilepsy
by: Anatolie Vataman, et al.
Published: (2023-04-01)

Increased migraine-free intervals with multifocal repetitive transcranial magnetic stimulation
by: Pavel Leahu, et al.
Published: (2021-11-01)

Interferons in relapsing remitting multiple sclerosis.
by: Goodin, D
Published: (2003)

Natalizumab for relapsing-remitting multiple sclerosis
by: A. Horga, et al.
Published: (2011-01-01)

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis
by: Jason M. Millward, et al.
Published: (2020-11-01)

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis
by: V. Casado, et al.
Published: (2021-07-01)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
by: Oliver Findling, et al.
Published: (2018-08-01)

Thalamic neurodegeneration in relapsing: Remitting multiple sclerosis
by: Cifelli, A, et al.
Published: (2003)